Specimen SS-F-AST-296 // ASTRINGENCY · IFI-A
Ellagitannin Engineering II-IV-B
Punica granatum
Pomegranate
Target Trait
2.5×
fold-change
Ellagic acid/ellagitannin scaffold accumulation
Technical Specifications
SKU
SS-F-AST-296
Genomic Edits
6
GC Content
47.3%
Construct Length
3,574 bp
Promoter System
T7/SP6 cell-free
Expression System
In-vitro cell-free
Host Strain
Cell-free
Receptor Target
Polyphenol-astringency axis
IFI Score
250
Pathway Edits
- UGGT overexpression (galloyl-UDP-glucosyltransferase) for galloyl-glucose scaffold initiation
- laccase-ELG upregulation for oxidative C-C galloyl coupling toward ellagic acid
- PGT polygalloylglucoside transferase amplification for ellagitannin polymerization
- cytochrome-b5 electron carrier co-expression for laccase-ELG redox support
- UGGT/laccase-ELG bicistron optimization for coupled galloylation-oxidation
- Cell-free wheat germ extract reconstitution system
- Enhanced flux via 5'UTR synthetic leader sequence optimization
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Specialty pomegranate extract development, intermediate ellagitannin research, nutraceutical prototype formulation. Enhanced variant for premium or research-grade applications requiring peak astringency fidelity.
License
$749 · Tier II License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?